Globe Newswire (Wed, 7-Jan 4:05 PM ET)
Globe Newswire (Fri, 2-Jan 4:05 PM ET)
Globe Newswire (Thu, 11-Dec 4:05 PM ET)
Terns Announces Pricing of Upsized $650 Million Public Offering
Globe Newswire (Tue, 9-Dec 11:30 PM ET)
Terns Announces Proposed Public Offering
Globe Newswire (Tue, 9-Dec 6:12 AM ET)
Globe Newswire (Mon, 8-Dec 2:45 PM ET)
Terns Pharmaceuticals’ Jefferies Conference Appearance Highlights Advancements in Oncology Portfolio
Market Chameleon (Mon, 17-Nov 6:19 AM ET)
Terns Pharmaceuticals Highlights Innovative Cancer Therapy at Jefferies Global Healthcare Conference
Market Chameleon (Mon, 17-Nov 4:27 AM ET)
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Globe Newswire (Fri, 14-Nov 4:05 PM ET)
Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Globe Newswire (Mon, 10-Nov 4:05 PM ET)
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Terns Pharmaceuticals trades on the NASDAQ stock market under the symbol TERN.
As of January 21, 2026, TERN stock price climbed to $36.60 with 470,569 million shares trading.
TERN has a beta of 1.14, meaning it tends to be more sensitive to market movements. TERN has a correlation of 0.03 to the broad based SPY ETF.
TERN has a market cap of $3.98 billion. This is considered a Mid Cap stock.
In the last 3 years, TERN traded as high as $48.26 and as low as $1.87.
The top ETF exchange traded funds that TERN belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.
TERN has outperformed the market in the last year with a return of +726.2%, while the SPY ETF gained +15.0%. In the last 3 month period, TERN beat the market returning +324.6%, while SPY returned +1.5%. However, in the most recent 2 weeks TERN has underperformed the stock market by returning -4.5%, while SPY returned -1.8%.
TERN support price is $35.22 and resistance is $37.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TERN shares will trade within this expected range on the day.
